Nine’s acting chief executive, Matt Stanton, will continue the cost-cutting program for two more years and says the company ...

Biocon share rose after Biocon Biologics, a subsidiary of Biocon, announced that Yesintek (ustekinumab-kfce) is now available ...

CAG reports will highlight alleged issues in the renovation of the Chief Minister's residence and Mohalla clinics under the ...